BRIAN THACKER: Open Payments
NPI 1275037145 · LORIS, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 45 payments from 18 companies in 2025. Trend: 2023 $907 · 2024 $1,231 · 2025 $844
Food & beverage: $844
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $167 |
| PFIZER INC. | 5 | $101 |
| Dexcom, Inc. | 3 | $72 |
| Novo Nordisk Inc | 3 | $64 |
| Amgen Inc. | 4 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Abbott Laboratories | 2 | $48 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| Averitas Pharma Inc. | 1 | $36 |
| ABBVIE INC. | 2 | $28 |
Products named: FARXIGA, PREVNAR 20, Dexcom G6 Transmitter, OTEZLA, JARDIANCE, FREESTYLE LIBRE 3, AIRSUPRA, Ozempic.
Industry payments across SC — which companies pay providers there.
